ADVERTISEMENT
Image of a white cardboard box with a blue vertical stripe on the left side, the word “Apixaban” in blue lettering at the bottom, and a depiction of apixaban’s molecular structure in black.
Blood Thinner Ineffective for COVID-19 Patients: Study
A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.
Blood Thinner Ineffective for COVID-19 Patients: Study
Blood Thinner Ineffective for COVID-19 Patients: Study

A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.

A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.

coronavirus
close-up photo of fruit fly on white background
Scientists ID Heart-Damaging SARS-CoV-2 Protein
Grace van Deelen | Nov 22, 2022 | 3 min read
In flies and mice, a viral protein increases the rate of energy use by heart cells. But it’s not yet clear if the finding applies to humans.
hundred-dollar bills disintegrating
FTX Collapse Imperils Philanthropic Research Funding
Shawna Williams | Nov 15, 2022 | 2 min read
Natural science research projects were among those promised funding by the now-collapsed crypto exchange’s “effective altruism” foundations.
Small Changes, Big Consequences
Small Changes, Big Consequences
Niki Spahich, PhD | 3 min read
To understand the mechanisms behind severe COVID-19, researchers identified common COVID-19 genetic risk variants that affect immune cell function.
Illustration of SARS-CoV-2
US Agency to Look into Project on Modified Coronavirus
Catherine Offord | Oct 18, 2022 | 3 min read
The National Institute of Allergy and Infectious Diseases was not aware that the work involved a chimeric strain of SARS-CoV-2, STAT reports.
several blue office chairs sit empty in a carpeted room, with a paper sign saying "Vaccination centre welcome" pasted on the white wall above. 
Is a Winter COVID-19 Case Surge Coming?
Katherine Irving | Oct 17, 2022 | 3 min read
Low booster rates and immune-evading SARS-CoV-2 variants could spell bad news, experts say. 
Characterizing Proteolysis During SARS-CoV-2 Infection
Characterizing Proteolysis During SARS-CoV-2 Infection
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | 1 min read
Edward Emmott will discuss mass spectrometry approaches to understand proteolysis during viral infection and their use in developing targeted strategies for COVID-19 treatment.
A person in a white shirt activates a nasal spray
Oxford-AstraZeneca Nasal COVID-19 Vaccine Falters in Clinical Trial
Dan Robitzski | Oct 11, 2022 | 2 min read
Researchers say they’re abandoning the project in its current form—one of several that aims to induce what’s known as mucosal immunity against SARS-CoV-2.
News feature
Vector image of black body with head surrounded by white clouds
Multiple Possible Causes of Long COVID Come into Focus
Natalia Mesa | Sep 28, 2022 | 10+ min read
Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  
Understanding COVID’s Long Game
Understanding COVID’s Long Game
The Creative Services Team in collaboration with Cayman Chemical | 1 min read
Floyd Chilton and Thomas Bumol shine light on the pathways that SARS-CoV-2 hijacks to cause disease.
A surgical mask next to an open pill bottle that’s toppled over, spilling out red capsules meant to represent vitamin D supplements.
Vitamin D Likely Doesn’t Prevent COVID-19, Studies Find
Dan Robitzski | Sep 9, 2022 | 2 min read
The results from two large clinical trials don't support the idea that supplements of the vitamin bolster immune defenses against SARS-CoV-2.
the Melbourne skyline with lake in foreground
New Australian Center Will Develop Therapies for Future Pandemics
Shawna Williams | Aug 31, 2022 | 2 min read
Launched with a $172 million philanthropic donation and funds from the state of Victoria, the Melbourne-based research institute aims to construct drug discovery platforms to speed the introduction of new therapies.
800x560-october-20-2021
Keeping Pace With SARS-CoV-2 Evolution
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | 1 min read
Eugene Koonin and Eric Niederkofler discuss novel technologies to improve viral mutation surveillance.
Small vaccine bottles on a conveyer belt
Pfizer and Moderna COVID-19 Omicron Boosters Get OK from the FDA
Catherine Offord | Aug 31, 2022 | 3 min read
The immunizations are designed to target the latest Omicron subvariants, and are only authorized for people who have already received their primary vaccinations.
Illustration of several warped and stretched analog clocks swirling around a central point.
It’s Not Just You: Lockdowns Had Us Living in “Blursday,” Study Says
Dan Robitzski | Aug 26, 2022 | 6 min read
The Scientist spoke with Maximilien Chaumon about his database showing how COVID-19 related lockdowns warped more 2,800 people’s perception of time.
800x560-misherlock-0916
A New COVID-19 Spit Test Is as Easy as 1-2-3
Roni Dengler, PhD | 4 min read
A device smaller than two stacked decks of cards can reliably detect and discriminate between SARS-CoV-2 variants in spit in less than an hour with results that glow.
Anthony Fauci
Anthony Fauci Announces Departure from NIAID, Advisory Roles
Catherine Offord | Aug 22, 2022 | 2 min read
The 81-year-old director says that he will step back from his positions this December, but that he will continue working to advance science and public health.
An illustration of a pregnant women wearing a mask, surrounded by microbes
How COVID-19 Affects Pregnancy
Amanda Heidt | Aug 16, 2022 | 10 min read
Evidence thus far shows that pregnant people infected with SARS-CoV-2 are at higher risk for severe disease and death, as well as complications in their pregnancies.
Approaches to Processing SARS-CoV-2 Samples for RNA Detection
The Scientist Creative Services Team in collaboration with MilliporeSigma | 1 min read
Discover new RNA extraction and purification strategies and how they enable reliable and sensitive viral detection.
A translucent illustration of the BA.2.75 subvariant of SARS-CoV-2 against a black background
Experts Mixed on Risk of “Centaurus” Omicron Subvariant
Dan Robitzski | Aug 15, 2022 | 3 min read
BA.2.75 is spreading rampantly in India and has so far reached at least 20 other countries, but it doesn’t seem to be outcompeting other Omicron SARS-CoV-2 subvariants.
ADVERTISEMENT